ISSN 0103-507X printed version
ISSN 1982-4335 online version

INSTRUCTIONS TO AUTHORS

 

Scope and Policy

RBTI is a medical journal with critical review aiming at improving critically ill patients' care through discussion, distribution and promotion of information based on relevant evidences to professionals involved with Intensive Care Medicine. It publishes researches, consensus, case reports and comments in all areas of knowledge related to critically ill patients' intensive care.

RBTI accepts high-quality research in any area related to intensive care. All submitted papers are reviewed by at least two reviewers. All reviewers are asked to answer in pairs their initial evaluations in 4 to 6 weeks. RBTI target-audience is its members and all intensive care medicine partners, be them physicians, physical therapists, nurses, psychologists, speech therapists or nutritionists.

 

Format and preparation of manuscripts

INSTRUCTIONS FOR AUTHORS

Revista Brasileira de Terapia Intensiva (Rev Bras Ter Intensiva, RBTI) ISSN 0103-507X, is the Associação de Medicina Intensiva Brasileira (AMIB)'s quarterly issued scientific journal, aimed to publish relevant research involving acutely ill patients health care improvement, providing evidence-based information discussion, distribution and promotion to intensive care professionals. It publishes research, review, comments and case report articles and letters to the Editor in all areas related to severely ill patient's care.
The manuscripts can be either submitted in English, Portuguese or Spanish. RBTI is published in a Portuguese printed version, and a Portuguese and English electronic version. The journal will translate the articles submitted in Portuguese
(or Spanish) and the translation costs will be covered by the journal. Articles submitted in English will be translated by the journal into Portuguese, with no expenses to the authors.
The submitted manuscripts will be initially checked by the Editor regarding the minimal journal requirements and fulfillment of all manuscript submission rules. Manuscripts without merit, bearing significant methodology errors, or not fitting the journal's editorial policy will be rejected, with no room for appeal. After the Editor's approval, the articles will be forwarded for analysis by two or more reviewers. These will always be from institutions that are different from the one the manuscript is from, being the anonymous condition kept during the entire editorial process. The opinions expressed in the articles, including reviewer-requested changes, will be the only authors' responsibility. The time for the analysis is 30 days. After receiving the reviewers' opinion, the authors will be allowed 60 days to submit a new version including the suggested changes. If not submitted within 6 months, the manuscript will be removed from the data bank and an eventual resubmission will follow the initial submissions track.
All submitted manuscripts should be accompanied by a letter signed by all authors authorizing its publication, transferring copyright to the journal, as well as declaring its originality, and that it was/is not submitted for publication in any other journal.

This letter should have attached:
  • Conflict of Interest Declaration, when appropriate. According to the Federal Medical Council Decision #1595/2000 the Conflict of Interest Declaration prohibits that any commercial products or equipments are promoted or advertised in the article.
  • Certificate of Approval by the Ethics Committee of the Institution where the study was developed, or from another constituted EC.
  • Information on eventual funding/financial support sources.
  • For manuscripts including clinical information or pictures related to individual patients, a signed (by the patient or a family member) Informed Consent Form should be submitted for each patient.

Any either clinical or experimental, human or animal studies should have been conducted in compliance with the Declaration of Helsinki, and this should be mentioned on the section Methods.
Authorship criteria
Should be considered authors only those directly contributing to the article's intellectual contents, according to the criteria below:
1. Created the initial idea and planned the study or interpreted the final results OR
2. Wrote the manuscript or revised its successive versions AND
3. Approved the final version.
Administrative positions and data collection are not considered criteria for authorship and, when appropriate, should be included in the Acknowledgements session.

MANUSCRIPT

All articles should include:

Title page:

  • Full title of the article
  • All authors full names
  • Each author institutional affiliation (only the main affiliation, i.e. affiliation to the institution where the work was developed).
  • Author for correspondence's complete address (including phone and fax numbers and email).
  • The Institution to be considered as responsible for sending the article.
  • The project's funding source.
  • Running title - An alternative title for the article, containing up to 60 characters with spaces. This title should be displayed in all article's sheet headings.
  • Cover title - When the article's title has more than 100 characters with spaces, an alternative title should be provided, including up to 100 characters (with spaces) to be displayed in the journal's cover.

Abstracts

Portuguese abstract: The Portuguese abstract should have up to 250 words, and avoid abbreviations as far as possible. It should be structured with the same chapters as the main text (Objective, Methods, Results and Conclusion), and accurately reflect the main text contents. When the articles are Reports or Case Report, the abstract doesn't need to be structured.
Summary Comments should be shorter than 100 words.
English Abstract: The English abstract has only to be provided for manuscripts in this language. Manuscripts submitted in Portuguese will have their Abstract translated into English.

Keywords

Six Portuguese and English terms should be provided defining the paper's subject. These should be based on the DeSC (Health Sciences Descriptors), a translation of the National Library of Medicine's MeSH (Medical Subject Headings), available at http://decs.bvs.br.

Text

The articles should be submitted in MS Word® file with Times New Roman 12 font, double space, including for tables, legends and references. In all article categories the references should be numerical, superscripted, and sequential.

Original articles

Are articles presenting investigational results. The text should have up to 5000 words, excluding the title sheet, abstract, tables and references. Articles larger than this should be approved by the Editor. The maximal recommended number of authors is eight. If more authors have to be included, this should be justified, explaining each author's participation. Original articles should have:
Introduction - This section should be written from a non area expert stand point, and clearly provide - and if possible, illustrate - the rational for the research and its objectives. Clinical trial reports should, whenever appropriate, include a literature research abstract, indicating why the study was needed and the aimed study contribution. This section should end with a short statement on the article reported subject.
Methods - This should include the study design, the scenario, type of participants or materials, clear interventions and comparisons description, type of analysis used and their statistical power, if appropriate.
Results - The results should be presented in clear and logical sequence. The statistical analysis results should include, when appropriate, the relative and absolute risks or risk reductions, and confidence intervals.
Discussion ­­- All results should be discussed and compared to the relevant literature.
Conclusion - Should clearly discuss the main research conclusions and provide clear explanation on its relevance.
References - Should be sequential according to the order of quotation on text, and limited to 30 references. See below the reference rules.

Review articles
A review article is a comprehensive description of certain health care aspects relevant to the journal scope. Should have no more than 4000 words (except the title sheet, abstract, tables and references) and up to 50 references. Should be written by acknowledgeable experienced authors, and the authors number should not exceed three, except justification to be submitted to the journal. The reviews may include: scientific reviews - describing clinical impact sciences; "bedside bench" reviews - describing the science supporting clinical situations; clinical reviews - describing purely clinical situations. In reviews it is also recommended having a "Methods" section, reporting the evidence sources and the key words used for the literature search. Systematic literature reviews containing appropriate search strategies and results are considered original articles.


Pro/Cons clinical debates

Two invited authors discuss their different opinions on a specific clinical subject. The subjects are identified in clinical scenarios written by the section editor. Each author is requested to write a 800-1000 words referenced article, describing if/why they agree or disagree with the clinical scenario (Pro or Con). The con articles are show to the authors for a shorter than 150 words response. The authors know who their opponent is, but can't see the opposed article before submitting their own. The 500 words article should have no more than 15 references, and the 150 words response, 5 references. Randomized controlled studies published in the last 10 years are preferable.

Comments
Are expert-written opinion articles, to be read by the general medical community. Many are solicited, however unsolicited articles are also welcome, and routinely revised. The comment objective should be highlighting an issue, expanding the highlighted subject, and suggesting the sequence. Any statement should be referenced, however it is preferable that the reference list is limited to 15. For readability, the sentences should be short and objective. Use subtitles for dividing the comments section. This should be short, up to 800 to 1000 words, except the abstract and references. The number of authors should not exceed two, unless justified.
Research comments
Research articles are frequently accompanied with comments. They aim to describe the research qualities and/or faults, and its widened implications. The research article discussed should be the first reference.
Recent publications comments
Last 6 months published research articles are elected by the editorial board, reporting them as a comment.

Letters to the Editor
Comments to any article published in the journal, being an author's or editor's response pertinent. Rebutter is not allowed. These should have up to 400 words, up to 5 references, being the subject RBTI's article the first mention in the text and references. The authors should also submit their complete identification and address (including phone number and email). All letters are edited and sent back to the authors before publication.

Acknowledgements
The authors should use this section to thank eventual research funding and academic organisms' support; foment agencies; colleagues and other collaborators. The authors should grant permission from all mentioned in the acknowledgments section. This should be concise, not exceeding 4 lines.

References
Should be updated, preferably containing the most relevant articles published on the subject in the last five years. Should not contain articles not quoted in text or unpublished works. The references should be consecutively numbered in the text quotation sequence, and identified with Arabic numerals. The display should comply with the Vancouver Style format, as in the models below. The journal titles should be abbreviated according to the National Library of Medicine, available at the List of Journal Indexed in Index Medicus, at http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=journals.
For all references, mention up to six authors. In case of more than six authors, mention the first six authors followed by the expression et al.

Printed Articles
Dellinger RP, Vincent JL, Silva E, Townsend S, Bion J, Levy MM. Surviving sepsis in developing countries. Crit Care Med. 2008;36(8):2487-8.

Levy MM, Vincent JL, Jaeschke R, Parker MM, Rivers E, Beale R, et al. Surviving Sepsis Campaign: Guideline Clarification. Crit Care Med. 2008;36(8):2490-1.

Electronic Articles
Buerke M, Prondzinsky R. Levosimendan in cardiogenic shock: better than enoximone! Crit Care Med [Internet]. 2008 [cited 2008 Aug 23];36(8):2450-1. Available from: http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200808000-00038.htm
;jsessionid=LWTRDHyTFs6cTtCHrnxTjpHBBvkgdDG7qVyn12SGJw1dn99ynQ4W!1177656273!181195629!8091!-1

Hecksher CA, Lacerda HR, Maciel MA. Características e evolução dos pacientes tratados com drotrecogina alfa e outras intervenções da campanha "Sobrevivendo à Sepse" na prática clínica. Rev Bras Ter Intensiva [Internet]. 2008[citado 2008 Ago 23; 20(2): 135-43. Available at: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-507X2008000200004&lng=pt&nrm=iso>.
ISSN 0103-507X

Supplements
Walker LK. Use of extracorporeal membrane oxygenation for preoperative stabilization of congenital diaphragmatic hernia. Crit Care Med. 1993;21 (Supp. l):S379-S380.

Books
Doyle AC. Biological mysteries solved. 2nd ed. London: Science Press; 1991.

Book chapters
Lachmann B, van Daal GJ. Adult respiratory distress syndrome: animal models. In: Robertson B, van Golde LM. Pulmonary surfactant. 2nd ed. Amsterdam: Elsevier; 1992. p. 635-66.

Published abstracts
Varvinski AM, Findlay GP. Immediate complications of central venous cannulation in ICU [ abstract]. Crit Care. 2000;4(Suppl 1):P6.

In press articles
Beigel JH. Influenza.Crit Care Med. In press 2008.

Tables and figures
All figures and tables should be numbered according to the text mention order. Tables and figures should be inserted below the text, following references, only one each page, the later preferably prepared as MS Excel®, TIF, or JPG with 300 DPI files. Figures needing increased resolution should be submitted in files apart. Figures containing texts should be provided in open files, for translation. If not possible, the author should provide the translation.
The quantities, units and symbols used should adhere to national rules. The tables and figures legends should be concise but self-explaining, allowing understanding without consulting the text. The units should be in the table's body, and statistical tests indicated below the table.
The figures should have legends explaining the results, allowing understanding without consulting the text. Surgery and biopsy pictures with special staining techniques will be considered for color printing, being the additional costs the authors' responsibility. Already published figures should be accompanied with the author/editor authorization.
Reproduced figures, charts, plots or tables, not originally belonging to the article, should reference the original source.

Abbreviations and initials
The use of abbreviations should be avoided in the article's title, abstract and tables and figures headings. Their use should be minimized in the entire text. They should be preceded by the entire name when first mentioned in the text. The abbreviations, symbols and other signs meanings should be provided in the figures and tables foot notes.

 

Sending the manuscript

The articles should be electronically submitted at www.rbti.org.br or by email rbti.artigos@amib.org.br.

© 2008 Associação de Medicina Intensiva Brasileira - AMIB
The figures, plots and pictures quality are the exclusive authors' responsibility.


The correspondence to the journal should be forwarded to:

RBTI - Revista Brasileira de Terapia Intensiva

Associação de Medicina Intensiva Brasileira
Rua Joaquim Távora, 724 - Vila Mariana - CEP 04015-011 - São Paulo - SP
Phone: (11) 5089-2642 - E-mail: rbti.artigos@amib.org.br

 

[Home] [About the journal] [Editorial board] [Subscriptions]


Creative Commons License All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License

Rua Joaquim Távora, 724 Vila Mariana
CEP 04015-001 São Paulo SP Brasil
Tel./Fax: +55 11 5089-2642


rbti.artigos@amib.org.br